Efficacy and Safety of Aromatase Inhibitor Combined with Growth Hormone in Korean Boys with Idiopathic Short Stature: A ...

Aromatase inhibitors are an important component of the adjuvant treatment of hormone receptor-positive breast cancer, but the cardiovascular safety of these drugs has remained unclear. The results are ...

December 9, 2010 (UPDATED December 10, 2010) (San Antonio, Texas) — The use of aromatase inhibitors for any length of time by postmenopausal women with breast cancer is associated with a significant ...

Biotech stock Olema Pharmaceuticals catapulted to a four-year high Tuesday after Roche unveiled positive results in breast ...

Two-thirds of breast tumours are oestrogen-receptor positive and 60–70% of these tumours respond to interventions that reduce the effects of oestrogen. Until recently, tamoxifen was the drug of choice ...

More than 100,000 women each year are diagnosed with a type of breast cancer called postmenopausal estrogen receptor-positive -- the most common type of breast cancer. Studies in recent years have ...

Credit: Getty Images. Breast cancer patients with obesity may derive less of a benefit from aromatase inhibitors than patients of a “healthy” weight, according to researchers. Breast cancer patients ...

Using the yeast one-hybrid approach to screen a human breast tissue hybrid cDNA expression library, we have found that four orphan/nuclear receptors, ERRα-1, EAR-2, COUP-TFI (EAR-3), and RARγ, bind to ...

Aromatase inhibitors are a class of hormonal agents that form part of the therapy for some types of breast cancer. These agents are available as pills and may be started after initial surgery or ...

BOSTON — In adolescent boys with idiopathic short stature, combination therapy with growth hormone and aromatase inhibitors was more effective in increasing adult height potential than growth hormone ...

Femara showed reduced risk of death by 13% (P=0.08), despite inclusion of patients crossing over from tamoxifen to Femara therapy In a separate censored analysis excluding patients after they crossed ...

How Effective Is Dose-Intensive/Myeloablative Therapy Against Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Metastatic to Bone or Bone Marrow? The Memorial Sloan ...